Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Announcing the new Tapestri scMRD Assay for AML. Learn More
X
Scientific presentation

Secondary data analysis part 2: variant selection


Robert Durruthy-Durruthy
Description

In the second session of a three-part series, Dr. Robert Durruthy-Durruthy, from the Mission Bio Support Team, walks through secondary data analysis using the Tapestri Insights software, going in-depth into variant selection. Which variants are important? Either use pre-selected variants uploaded via a whitelist, or explore impactful variants that are in coding regions of genes or have been previously reported as pathogenic in one of several clinical databases. Part 2/3.



VIEW


Scientific presentation
AML Single-cell Multi-omics MRD (scMRD) and the Horizon of Clinical Utility
Aaron Llanso
AMP 2022 (2022)
Scientific presentation
Molecular Analysis of Acute Myeloid Leukemia in Morphologic Remission
Sanam Loghavi, MD
AMP 2022 (2022)
Scientific presentation
Considerations, Strategies, and Advances in Early Drug Development to Mitigate Clinical Holds and Achieve Successful CGT Outcomes
Azadeh Golipour, PhD, AVROBIO
J. Kelly Ganjei, AmplifyBio
Scott R. Burger, MD, Advanced Cell and Gene Therapy
Matthew Cato
(2022)
Scientific presentation
Overview on Mission Bio’s Applications
Simone Formisano
Mission Bio EU Heme Symposium (2022)
REQUEST QUOTE